Periodontal Condition in Patients with Bronchial Asthma: Influence of the Disease and Its Pharmacotherapy

Bronchial asthma is a chronic inflammatory respiratory tract disease which affects more than 300 million people worldwide and is expected to increase substantially. Its treatment mainly includes inhaled bronchodilators, corticosteroids and anticholinergic agents that improve patency of airways. Prolonged use of these medications has been linked to negative oral health effects such as decreased salivary secretion, enamel demineralization and susceptibility to periodontal inflammation and candidiasis. However, the mechanisms and degree of periodontal impairment in asthmatic patients under long term pharmacotherapy are insufficiently explored. In spite of the association of asthma drugs with oral changes, few studies have comprehensively assessed the multifactorial effect of asthma drugs on periodontal tissues and salivary function, especially in the populations of Central Asia. The purpose of this study was to analyze the impact of bronchial asthma and its pharmacological treatment on periodontal health taking into consideration the connection between decreased salivation, changes of immunity and periodontal inflammation. Studies have shown that beta-2-agonists and corticosteroids have significant effects in reducing the secretion and protective function of saliva, which results in the accumulation of plaques, enamel demineralization and inflammatory periodontal disease. Inhaled corticosteroids have also been associated with decreased bone mineral density and increased IgE-mediated inflammatory responses. The study shows the regional aspect from Uzbekistan and CIS countries, with a focus on the clinical evidence of periodontal changes in asthmatics and offers recommendations for special preventive measures. Understanding the interaction between asthma treatment and oral health can be used to guide individual preventive and therapeutic approaches to ensure periodontal integrity of patients on long-term inhalation therapy.

Publication Details

Journal
Springer Link (Chiba Institute of Technology)
Published
2025-12-12
DOI
https://doi.org/10.1051/bioconf/202520401012/pdf
Primary Topic
Oral microbiology and periodontitis research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Periodontal Condition in Patients with Bronchial Asthma: Influence of the Disease and Its Pharmacotherapy

Springer Link (Chiba Institute of Technology)
Oral microbiology and periodontitis research
article

Periodontal Condition in Patients with Bronchial Asthma: Influence of the Disease and Its Pharmacotherapy

article en

Abstract

Bronchial asthma is a chronic inflammatory respiratory tract disease which affects more than 300 million people worldwide and is expected to increase substantially. Its treatment mainly includes inhaled bronchodilators, corticosteroids and anticholinergic agents that improve patency of airways. Prolonged use of these medications has been linked to negative oral health effects such as decreased salivary secretion, enamel demineralization and susceptibility to periodontal inflammation and candidiasis. However, the mechanisms and degree of periodontal impairment in asthmatic patients under long term pharmacotherapy are insufficiently explored. In spite of the association of asthma drugs with oral changes, few studies have comprehensively assessed the multifactorial effect of asthma drugs on periodontal tissues and salivary function, especially in the populations of Central Asia. The purpose of this study was to analyze the impact of bronchial asthma and its pharmacological treatment on periodontal health taking into consideration the connection between decreased salivation, changes of immunity and periodontal inflammation. Studies have shown that beta-2-agonists and corticosteroids have significant effects in reducing the secretion and protective function of saliva, which results in the accumulation of plaques, enamel demineralization and inflammatory periodontal disease. Inhaled corticosteroids have also been associated with decreased bone mineral density and increased IgE-mediated inflammatory responses. The study shows the regional aspect from Uzbekistan and CIS countries, with a focus on the clinical evidence of periodontal changes in asthmatics and offers recommendations for special preventive measures. Understanding the interaction between asthma treatment and oral health can be used to guide individual preventive and therapeutic approaches to ensure periodontal integrity of patients on long-term inhalation therapy.

Springer Link (Chiba Institute of Technology)
Good health and well-being
Openalex Percentile: Top 35%
Oral microbiology and periodontitis research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.